NASDAQ: ARVNArvinas Inc Stock Ownership - Who owns Arvinas?
Insider buying vs selling
Have Arvinas Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Noah Berkowitz | Chief Medical Officer | 2026-03-18 | 6,435 | $11.10 | $71.43kSell |
| Briggs Morrison | Director | 2026-03-06 | 20,000 | $13.40 | $268.06kBuy |
| John G. Houston | Director | 2026-02-27 | 4,688 | $13.24 | $62.07kSell |
| John G. Houston | Director | 2026-02-27 | 18,822 | $13.24 | $249.20kSell |
| John G. Houston | Director | 2026-02-27 | 11,787 | $13.14 | $154.88kSell |
| Randy Teel | President and CEO | 2026-02-23 | 1,038 | $12.16 | $12.62kSell |
| David K. Loomis | Chief Accounting Officer | 2026-02-23 | 1,108 | $12.16 | $13.47kSell |
| Angela M. Cacace | Chief Scientific Officer | 2026-02-23 | 1,038 | $12.16 | $12.62kSell |
| Angela M. Cacace | Chief Scientific Officer | 2026-02-23 | 2,571 | $12.16 | $31.26kSell |
| Randy Teel | President and CEO | 2026-02-23 | 3,748 | $12.16 | $45.58kSell |
ARVN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARVN insiders and whales buy or sell their stock.
ARVN Shareholders
What type of owners hold Arvinas Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 11.45% | 7,322,501 | $75.57M | Institution |
| Vanguard Group Inc | 11.30% | 7,229,603 | $74.61M | Institution |
| Timothy M. 1. Shannon | 9.73% | 6,223,325 | $64.22M | Insider |
| D E Shaw Co Inc | 5.77% | 3,689,201 | $38.07M | Institution |
| Canaan IX LP | 5.61% | 3,589,554 | $37.04M | Insider |
| Pfizer Inc | 5.41% | 3,457,815 | $35.68M | Institution |
| Ra Capital Management LP | 4.91% | 3,138,412 | $32.39M | Insider |
| Tcg Crossover Management LLC | 4.17% | 2,666,216 | $27.52M | Institution |
| Point72 Asset Management LP | 3.62% | 2,315,361 | $23.89M | Institution |
| Craig Martin Crews | 3.29% | 2,106,692 | $21.74M | Insider |
ARVN vs Biotech Stocks
Arvinas Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.